Contact Information: Contact: Stephanie Marks for Insulet Corporation 877-PODD-IR1 (877-763-3471)
Insulet Corporation to Present at the JMP Securities Healthcare Focus Conference
| Source: Insulet Corporation
BEDFORD, MA--(Marketwire - September 25, 2009) - Insulet Corporation (NASDAQ : PODD ), the leader
in tubing-free insulin pump technology with its OmniPod® Insulin
Management System, today announced the company will participate in the JMP
Securities Healthcare Focus Conference. Management is scheduled to present
an overview of the Company at 11:00 a.m. ET on October 5, 2009 at The New
York Palace Hotel.
During these conference presentations, material information concerning the
Company, its operations, strategies and prospects may be discussed. To
listen to the audio webcast of these presentations during the event, please
visit: http://investors.insulet.com. A replay of each webcast will be
available for 30 days.
About Insulet Corporation
Insulet Corporation is an innovative medical device company dedicated to
improving the lives of people with diabetes. The Company's OmniPod Insulin
Management System is a revolutionary, discreet and easy-to-use insulin
infusion system that features two easy-to-use parts with no tubing and
fully-automated cannula insertion. Through the OmniPod System, Insulet
seeks to expand the use of insulin pump therapy among people with
insulin-dependent diabetes. Founded in 2000, Insulet is based in Bedford,
MA.